Personal information

No personal information available

Activities

Employment (1)

Instituto Mexicano del Seguro Social: Ciudad de Mexico, DF, MX

2008-03-01 to present (UMAE Especialidades Centro Medico La Raza Servicio de Hematologia)
Employment
Source: Self-asserted source
Alvaro Hernandez-Caballero

Works (7)

FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias.

Archives of medical research
2020-10-24 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Post-treatment improvement of NK cell numbers predicts better survival in myeloma patients treated with thalidomide-based regimens.

International journal of hematology
2019-06-05 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.

Archives of medical research
2018-01-01 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Genetic susceptibility variants for chronic lymphocytic leukaemia in Mexican mestizos.

British journal of haematology
2014-12-18 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry.

Clinical lymphoma, myeloma & leukemia
2011-02-01 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.

Clinical lymphoma, myeloma & leukemia
2011-02-01 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero

Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico.

Human biology
2007-02-01 | Journal article
Source: Self-asserted source
Alvaro Hernandez-Caballero